1. Home
  2. SOPH vs EOLS Comparison

SOPH vs EOLS Comparison

Compare SOPH & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$5.38

Market Cap

374.1M

Sector

Health Care

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.78

Market Cap

407.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
EOLS
Founded
2011
2012
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
374.1M
407.0M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
SOPH
EOLS
Price
$5.38
$6.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$7.50
$15.50
AVG Volume (30 Days)
333.8K
757.7K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$23.09
$13.27
Revenue Next Year
$19.57
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$2.83
$3.86
52 Week High
$6.30
$10.20

Technical Indicators

Market Signals
Indicator
SOPH
EOLS
Relative Strength Index (RSI) 50.94 56.52
Support Level $4.59 $6.44
Resistance Level $5.65 $6.95
Average True Range (ATR) 0.40 0.31
MACD 0.02 -0.02
Stochastic Oscillator 36.24 53.33

Price Performance

Historical Comparison
SOPH
EOLS

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: